Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2759 (LINC02759) is a human gene that produces a long non-coding RNA transcript, not translated into protein. LINC02759 does not share overlap with coding regions and is part of a large class of non-coding RNAs termed lincRNAs, which are thought to regulate gene expression, often by influencing chromatin structure or interacting with other molecular components of the cell. The specific biological roles or disease associations of LINC02759 have not been established in the scientific literature to date. No evidence supports LINC02759 as a therapeutic target, receptor, enzyme, transporter, or other established pharmacologically drugged entity. It should not be classified as a conventional druggable target. There is also no indication that the gene name is misspelled or otherwise incorrect.
Not applicable; no drugs currently known to target this RNA
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2759 (LINC02759).